Eculizumab er udformet, så det bindes til komplementproteinet C5, der er en del af det forsvarssystem i organismen, der kaldes "komplement".
Eculizumab has been designed to bind to the C5 complement protein, which is part of the body’ s defence system called ‘ complement’.